A study out of Oslo, Norway, published in the New England Journal of Medicine questioned the effectiveness of colonoscopy in preventing colorectal cancer, the second deadliest cancer in the United States. The study triggered a swell of media reports casting doubt on the procedure.
Two stories occurring decades apart bookend one Virginia survivor’s journey with colorectal cancer. The first story takes place shortly before humans walked on the moon. The last happened just the other day.
While more than 20 million additional people will be able to get a preventive colorectal cancer screening, most at no cost, this change will not catch every colorectal cancer. We still have work to do.
A study this month by the Alliance of Community Health Plans and Academy of Managed Care Pharmacies shows that due to concerns about the COVID-19 virus Americans have altered their use of traditional health services with many delaying necessary care.
Dr. Andrew Albert—recently named by StreetWise as one of the “2018 Most Inspiring Chicagoans” for his work launching the grassroots awareness campaign #backoffcoloncancer—offers his thoughts on colorectal cancer screening.
Early in 2018, the American Cancer Society (ACS) lowered its recommended colorectal cancer screening start age from 50 to 45. The news made the popular headlines and may have prompted the question:What is the ACS and why do these recommendations matter? These are important questions to ask. As healthcare consumers, you’re encouraged to know your options and empower yourselves with updated and balanced information.